Clinical Trials Browser

Interventional × fluoromisonidazole × Clear all

NCT01507428 2026-04-21

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

Phase 2 Completed

138 enrolled 42 charts

Stage III Lung Non-Small Cell Cancer AJCC v7

NCT04309552 2026-01-27

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Phase 1 Suspended

Glioma

NCT02498613 2025-09-25

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Phase 2 Active not recruiting

122 enrolled 16 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02016872 2025-04-30

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Phase NA Completed

25 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

Phase 2 Recruiting

Brain Neoplasms

NCT05250895 2025-03-13

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Phase EARLY_PHASE1 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT06087614 2025-01-17

DE-HyART

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT01246869 2024-10-01

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Phase 1 Terminated

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neoplasms

NCT05996432 2024-09-23

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Phase EARLY_PHASE1 Recruiting

Squamous Cell Carcinoma of Head and Neck, Brain Neoplasms

NCT02695628 2024-01-31

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Phase 2 Completed

5 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT00606294 2023-06-28

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Phase NA Completed

216 enrolled 9 charts

Head and Neck Neoplasms

NCT01967927 2021-08-19

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

Phase EARLY_PHASE1 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasms

NCT03730077 2021-03-18

FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas

Phase 1 Terminated

Sarcoma

NCT03303469 2021-02-21

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Phase 2 Terminated

3 enrolled 4 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03573986 2020-02-17

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Phase 1 Terminated

Glioblastoma

NCT02471313 2019-04-23

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Phase 2 Completed

3 enrolled 5 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00902577 2019-04-08

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

50 enrolled 16 charts

Glioblastoma, Gliosarcoma

NCT01868906 2018-08-24

FMISOPETSCS

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT01169350 2017-11-17

18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

Phase 2 Terminated

8 enrolled 4 charts

Sarcoma

NCT00559377 2016-12-30

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

Phase 2 Completed

16 enrolled 7 charts

Uterine Cervical Neoplasms

NCT02061007 2016-05-09

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Phase 2 Withdrawn

Melanoma, Skin Neoplasms

NCT01254591 2013-08-26

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Phase NA Unknown

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Colorectal Neoplasms

NCT00544674 2012-12-10

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Phase 2 Terminated

5 enrolled 7 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01213030 2012-09-25

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Phase 1/2 Completed

GastrointestinalHead & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms

NCT00038038 2012-08-01

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole

Phase NA Withdrawn

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis

NCT00616213 2011-06-01

PR104 and G-CSF in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific